Is an endometrial thickness of 0.31 cm normal in a postmenopausal woman without abnormal uterine bleeding?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Is 0.31 cm (3.1 mm) Endometrium Normal?

Yes, an endometrial thickness of 3.1 mm is normal and reassuring in a postmenopausal woman without bleeding, with a negative predictive value for endometrial cancer approaching 100%. 1, 2

Clinical Context and Interpretation

In postmenopausal women without abnormal uterine bleeding, an endometrial thickness <4 mm effectively excludes endometrial malignancy. 1, 2 Your measurement of 3.1 mm falls well below this threshold and is considered atrophic endometrium, which is the expected finding in postmenopausal women. 3

Key Thresholds by Clinical Scenario

  • Postmenopausal women WITH bleeding: Endometrial thickness ≤4-5 mm has a negative predictive value for cancer of nearly 100% 1, 3, 4

  • Postmenopausal women WITHOUT bleeding: The threshold for concern is significantly higher at 11 mm, as the baseline cancer risk is much lower in asymptomatic women 5

  • Your measurement of 3.1 mm: This is below both thresholds and represents normal atrophic endometrium 6, 3

What This Means for Management

No immediate intervention is needed with an endometrial thickness of 3.1 mm in an asymptomatic postmenopausal woman. 2 The American College of Radiology confirms that measurements at this level are reassuring regardless of other factors such as estrogen levels. 2

Important Caveats

Endometrial thickness alone is not sufficient—the ultrasound report must also comment on endometrial appearance and texture. 2 Abnormal echogenicity or heterogeneous texture can indicate pathology even when thickness is normal. 2, 7

If you develop vaginal bleeding, immediate evaluation is required regardless of endometrial thickness. 1, 2 The presence of symptoms changes the clinical context entirely and warrants endometrial sampling. 1

Follow-Up Recommendations

Repeat transvaginal ultrasound in 3-6 months is reasonable to ensure endometrial thickness remains stable in asymptomatic postmenopausal women. 2

If endometrial thickness increases to ≥5 mm on follow-up imaging, endometrial tissue sampling becomes necessary. 2

For asymptomatic postmenopausal women, biopsy should be considered only if endometrial thickness exceeds 11 mm. 5 At 3.1 mm, you are far below this threshold with an extremely low cancer risk of approximately 0.002%. 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Elevated Estrogen with 4mm Endometrial Thickness

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Assessment of abnormal bleeding in menopausal women: an update.

The journal of the British Menopause Society, 2003

Research

How thick is too thick? When endometrial thickness should prompt biopsy in postmenopausal women without vaginal bleeding.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 2004

Research

Value of endometrial thickness measurement for diagnosing focal intrauterine pathology in women without abnormal uterine bleeding.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 2009

Guideline

Management of Heterogeneous Uterine Echotexture in Reproductive-Age Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.